Objective To observe the changes of plasma von Willebrand factor (vWF) and soluble E-selectin (sE-selectin) in patients with coronary artery disease (CAD) and evaluate their clinic significance.

• 目的：检测冠心病患者血浆血管性血友病因子(von Willebrand factor, vWF)及可溶性E-选择素(sol-uble E-selectin, sE-selectin)的变化，探讨其在冠心病发病机制、病情诊治及监测中的意义。